https://www.prnewswire.com/news-releases/phase-1a1b-study-results-of-akesos-pd-1ctla-4-bispecific-antibody-published-in-cell-reports-medicine-highlighting-promising-efficacy-in-solid-tumors-refractoryrelapsed-to-standard-therapy-301961659.html
/PRNewswire/ -- Akeso (9926. HK) announced the publication of the phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab (PD-1/CTLA-4...
study resultsphaseakesopd
https://www.newsfilecorp.com/release/280455/Global-Development-Accelerates-Leads-Biolabs-PDL141BB-Bispecific-Antibody-Granted-Fast-Track-Designation-by-FDA
Nanjing, China--(Newsfile Corp. - January 15, 2026) - Nanjing Leads Biolabs Co., Ltd. (HKE: 9887) ("Leads Biolabs" or the "Company")...
global developmentleadspdbispecific
https://pubmed.ncbi.nlm.nih.gov/18546289/?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Trifunctional bispecific antibodies can efficiently mediate tumor cell killing by redirecting T cells and immune accessory cells to the tumor cell. Here, we...
bispecific antibodynovelx
https://dedhamgroup.com/how-bispecific-antibody-therapies-are-impacting-community-practices-and-three-trends-to-watch/
Jan 9, 2025 - Learn how manufacturers can drive adoption of bispecific antibody therapies.
bispecific antibodycommunity practicestherapiesthree
https://www.pharmaceutical-technology.com/data-insights/xencor-gets-grant-for-bispecific-antibody-for-treating-gpc3-associated-cancers/
Discover Xencor Inc's groundbreaking patent for novel GPC3 binding domains and bispecific antibodies targeting GPC3-associated cancers. Explore the innovative...
bispecific antibodyxencorincfilespatent
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-anti-4-1bb-bispecific-antibody-hlx35
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
bispecific antibodydefinitionegfr
https://www.openpr.com/news/4360650/leads-biolabs-pd-l1-4-1bb-bispecific-antibody-opamtistomig
Press release - Getnews - Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Earns EU Orphan Drug Designation-Potential First-in-Class...
bispecific antibodyleadspd
https://www.businesswire.com/news/home/20250107874851/en/Biocytogen-and-Acepodia-Join-Forces-to-Advance-Bispecific-Antibody-and-Dual-Payload-ADCs-for-Treating-Complex-Tumors
Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a dual-payload bispecific antibody-...
join forcesbispecific antibodybiocytogenadvance